Market Research Logo

Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017

Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Gastrointestinal Stromal Tumor patients study in a new report ‘Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Gastrointestinal Stromal Tumor epidemiology, Gastrointestinal Stromal Tumor diagnosed patients, and Gastrointestinal Stromal Tumor treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Gastrointestinal Stromal Tumor derived from epidemiological analysis, percentage of patients diagnosed with Gastrointestinal Stromal Tumor, and percentage of patients treated with a therapy.

The study helps executives estimate Gastrointestinal Stromal Tumor market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Gastrointestinal Stromal Tumor prevalence, Gastrointestinal Stromal Tumor diagnosis rate, and Gastrointestinal Stromal Tumor treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Gastrointestinal Stromal Tumor Patient Flow
  • Gastrointestinal Stromal Tumor Prevalence
  • Gastrointestinal Stromal Tumor Diagnosed Patients
  • Gastrointestinal Stromal Tumor Treated Patients


1. Gastrointestinal Stromal Tumor: Disease Definition
2. Global Gastrointestinal Stromal Tumor Patient Flow
2A. Global Gastrointestinal Stromal Tumor Prevalence
2B. Global Gastrointestinal Stromal Tumor Diagnosed Patients
2C. Global Gastrointestinal Stromal Tumor Treated Patients
3. Gastrointestinal Stromal Tumor Patient Flow in the US
3A. Gastrointestinal Stromal Tumor Prevalence in the US
3B. Gastrointestinal Stromal Tumor Diagnosed Patients in the US
3C. Gastrointestinal Stromal Tumor Treated Patients in the US
4. Gastrointestinal Stromal Tumor Patient Flow in Europe
4A. Gastrointestinal Stromal Tumor Prevalence in Europe
4B. Gastrointestinal Stromal Tumor Diagnosed Patients in Europe
4C. Gastrointestinal Stromal Tumor Treated Patients in Europe
5. Gastrointestinal Stromal Tumor Patient Flow in Germany
5A. Gastrointestinal Stromal Tumor Prevalence in Germany
5B. Gastrointestinal Stromal Tumor Diagnosed Patients in Germany
5C. Gastrointestinal Stromal Tumor Treated Patients in Germany
6. Gastrointestinal Stromal Tumor Patient Flow in France
6A. Gastrointestinal Stromal Tumor Prevalence in France
6B. Gastrointestinal Stromal Tumor Diagnosed Patients in France
6C. Gastrointestinal Stromal Tumor Treated Patients in France
7. Gastrointestinal Stromal Tumor Patient Flow in Spain
7A. Gastrointestinal Stromal Tumor Prevalence in Spain
7B. Gastrointestinal Stromal Tumor Diagnosed Patients in Spain
7C. Gastrointestinal Stromal Tumor Treated Patients in Spain
8. Gastrointestinal Stromal Tumor Patient Flow in Italy
8A. Gastrointestinal Stromal Tumor Prevalence in Italy
8B. Gastrointestinal Stromal Tumor Diagnosed Patients in Italy
8C. Gastrointestinal Stromal Tumor Treated Patients in Italy
9. Gastrointestinal Stromal Tumor Patient Flow in UK
9A. Gastrointestinal Stromal Tumor Prevalence in UK
9B. Gastrointestinal Stromal Tumor Diagnosed Patients in UK
9C. Gastrointestinal Stromal Tumor Treated Patients in UK
10. Gastrointestinal Stromal Tumor Patient Flow in Japan
10A. Gastrointestinal Stromal Tumor Prevalence in Japan
10B. Gastrointestinal Stromal Tumor Diagnosed Patients in Japan
10C. Gastrointestinal Stromal Tumor Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Gastrointestinal Stromal Tumor Patient Flow, 2016
Table 2: Global Gastrointestinal Stromal Tumor Patient Flow Forecast, 2016 - 2025
Table 3: Gastrointestinal Stromal Tumor Patient Flow in the US, 2016
Table 4: Gastrointestinal Stromal Tumor Patient Flow Forecast in the US, 2016 - 2025
Table 5: Gastrointestinal Stromal Tumor Patient Flow in Europe, 2016
Table 6: Gastrointestinal Stromal Tumor Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Gastrointestinal Stromal Tumor Patient Flow in Germany, 2016
Table 8: Gastrointestinal Stromal Tumor Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Gastrointestinal Stromal Tumor Patient Flow in France, 2016
Table 10: Gastrointestinal Stromal Tumor Patient Flow Forecast in France, 2016 - 2025
Table 11: Gastrointestinal Stromal Tumor Patient Flow in Spain, 2016
Table 12: Gastrointestinal Stromal Tumor Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Gastrointestinal Stromal Tumor Patient Flow in Italy, 2016
Table 14: Gastrointestinal Stromal Tumor Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Gastrointestinal Stromal Tumor Patient Flow in UK, 2016
Table 16: Gastrointestinal Stromal Tumor Patient Flow Forecast in UK, 2016 - 2025
Table 17: Gastrointestinal Stromal Tumor Patient Flow in Japan, 2016
Table 18: Gastrointestinal Stromal Tumor Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Gastrointestinal Stromal Tumor Patient Flow, 2016
Figure 2: Global Gastrointestinal Stromal Tumor Patient Flow Forecast, 2016 - 2025
Figure 3: Gastrointestinal Stromal Tumor Patient Flow in the US, 2016
Figure 4: Gastrointestinal Stromal Tumor Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Gastrointestinal Stromal Tumor Patient Flow in Europe, 2016
Figure 6: Gastrointestinal Stromal Tumor Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Gastrointestinal Stromal Tumor Patient Flow in Germany, 2016
Figure 8: Gastrointestinal Stromal Tumor Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Gastrointestinal Stromal Tumor Patient Flow in France, 2016
Figure 10: Gastrointestinal Stromal Tumor Patient Flow Forecast in France, 2016 - 2025
Figure 11: Gastrointestinal Stromal Tumor Patient Flow in Spain, 2016
Figure 12: Gastrointestinal Stromal Tumor Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Gastrointestinal Stromal Tumor Patient Flow in Italy, 2016
Figure 14: Gastrointestinal Stromal Tumor Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Gastrointestinal Stromal Tumor Patient Flow in UK, 2016
Figure 16: Gastrointestinal Stromal Tumor Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Gastrointestinal Stromal Tumor Patient Flow in Japan, 2016
Figure 18: Gastrointestinal Stromal Tumor Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report